Legal treatment of feline infectious peritonitis in the Netherlands.

ABSTRACT: ObjectivesThe study aimed to assess the clinical efficacy, safety and outcomes of legally prescribed and compounded GS-441524, with or without prior remdesivir, in cats with confirmed or highly suspected feline infectious peritonitis (FIP) in the Netherlands. A standardised diagnostic and treatment protocol was used to evaluate clinical response, adverse effects and prognostic factors.MethodsThis prospective, multicentre study included 127 client-owned cats with FIP, enrolled between June and November 2023 from three Dutch veterinary clinics. Diagnosis followed American Association of Feline Practitioners (AAFP)/EveryCat guidelines, incorporating clinical findings, laboratory data, imaging, cytology and RT-qPCR performed on either fine-needle aspirates or effusion. Cats were treated for a

SUBMITTER: Knies M 

PROVIDER: S-EPMC12905063 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature